Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Chemmedchem|September 29, 2023
Recent Advances in Mitochondria-Localized Luminescent Ruthenium(II) Metallodrugs as Anticancer AgentsSushree Aradhana Patra, Gurunath Sahu, Sanchita Das, et al.
Dalton Transactions (Cambridge, England : 2003)|May 22, 2026
Mixed-ligand oxidovanadium complexes with anticancer potentialSanchita Das, Pratikshya Das Pattanayak, Deepika Mohapatra, et al.
Dalton Transactions (Cambridge, England : 2003)|May 26, 2022
Recent advancements on decarbonylation reactions assisted by Ru-complexes: Synthetic and mechanistic approachSushree Aradhana Patra, Rupam Dinda, Pratikshya Das Pattanayak, et al.
Chemical Communications (Cambridge, England)|August 8, 2023
Recent advancements of fluorescent tin(IV) complexes in biomedical molecular imagingGurunath Sahu, Sushree Aradhana Patra, Pratikshya Das Pattanayak, et al.
Chemistry, an Asian Journal|March 18, 2026
Organotin(IV) Azo Hydrazonates as Lysosome-Targeted Imaging and Anticancer AgentsSanchita Das, Pratikshya Das Pattanayak, Takahiro Sasamori, et al.
Inorganic Chemistry|April 19, 2023
LVVO-Ethyl Maltol-Based Metallodrugs (L2- = Tridentate ONO Ligands): Hydrophobicity, Hydrolytic Stability, and Cytotoxicity via ROS-Mediated ApoptosisGurunath Sahu, Sushree Aradhana Patra, Pratikshya Das Pattanayak, et al.
Inorganic Chemistry|October 14, 2022
Mitochondria-Targeted Luminescent Organotin(IV) Complexes: Synthesis, Photophysical Characterization, and Live Cell ImagingSushree Aradhana Patra, Gurunath Sahu, Pratikshya Das Pattanayak, et al.
ACS Applied Bio Materials|January 14, 2025
RuIII-Morpholine-Derived Thiosemicarbazone-Based Metallodrugs: Lysosome-Targeted Anticancer AgentsMonalisa Mohanty, Sanchita Das, Pratikshya Das Pattanayak, et al.
Pageof 5